Author Correction: Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma
- 14 April 2020
- journal article
- correction
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 26 (5), 803
- https://doi.org/10.1038/s41591-020-0864-x
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.This publication has 1 reference indexed in Scilit: